Printer Friendly

INTERMEDICS RELEASES STATEMENT ON JURY FINDINGS ON VENTRITEX

 ANGLETON, Texas, Dec. 18 /PRNewswire/ -- Intermedics Inc. today released the following:
 A jury in Federal Court in San Francisco found on Dec. 15, 1992, in "Intermedics, Inc. v. Ventritex et al" that certain design ideas claimed by Intermedics as trade secrets were not secret at the time the individual defendants, Michael Sweeny and Ben Pless, terminated their relationship with Intermedics. As a result, Ventritex Inc. (NASDAQ-NMS: VNTX) and Messrs. Sweeny and Pless were found not to have misappropriated six of 37 trade secrets Intermedics asserts Ventritex and Messrs. Sweeny and Pless misappropriated.
 Intermedics believes the jury findings are incorrect and will be reversed on appeal. The recently concluded trial is a small part of the overall claims asserted by Intermedics against Ventritex. Trial on the remaining 31 trade secrets has not been set. Many of the trade secrets, some of which were included in the recently concluded trial, are covered by patents owned by Intermedics. Intermedics remains committed to prosecute its patent infringement claims against Ventritex as soon as Ventritex receives FDA approval to sell its implantable defibrillator in the United States.
 -0- 12/18/92
 /CONTACT: T.C. Selman II, vice president of Intermedics, 409-848-4097/
 (VNTX)


CO: Intermedics Inc.; Ventritex Inc. ST: Texas, California IN: HEA SU:

GK-OS -- NY034 -- 8178 12/18/92 11:39 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 18, 1992
Words:217
Previous Article:ENDANGERED SPECIES RULING COULD DRIVE UP HOME COSTS, BUILDERS SAY
Next Article:OKIDATA'S 'STUDENTS ADDRESS THE INAUGURAL' ASKS STUDENTS TO FAX CLINTON TOPICS HE SHOULD DISCUSS IN INAUGURAL SPEECH
Topics:


Related Articles
MEDTRONIC, VENTRITEX ANNOUNCE AGREEMENT TO CROSS-LICENSE TACHYARRHYTHMIA PATENTS
STRYKER CORPORATION V. INTERMEDICS ORTHOPEDICS, INC.
St. Jude Medical And Ventritex To Merge
St. Jude Medical, Inc. Receives Complaint From Guidant
St. Jude Medical Receives Request from FTC on Ventritex Merger
St. Jude Medical Responds to Ventritex Product Advisory
Sulzer Medica Announces FDA Approval for New Cost-Effective DDDR Pacemaker
St. Jude Medical and Ventritex Amend Merger Agreement
St. Jude Medical Reports Second Quarter 1997 Operating Results
Sulzer Intermedics Announces 1st Implant of Its New Defibrillator Lead

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters